Impact of tocilizumab administered intravenously or subcutaneously on patient-reported quality-of-life outcomes in patients with rheumatoid arthritis
Vibeke Strand, Margaret Michalska, Christine Birchwood, Jinglan Pei, Katie Tuckwell, Rebecca Finch, Alan J Kivitz, Josef S Smolen, Gerd R Burmester
RMD Open Jun 2018, 4 (1) e000602; DOI: 10.1136/rmdopen-2017-000602